A Study in Healthy Volunteers to Assess the Effect of Fedovapagon on the QT/QTC Interval

NCT02537288 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

43

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: Fedovapagon
DRUG: Moxifloxacin
DRUG: Placebo (for fedovapagon)

Sponsor

Vantia Ltd